Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis
Public ClinicalTrials.gov record NCT04440189. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Use of GID SVF-2 Device to Produce Autologous Adipose-Derived Stromal Vascular Fraction for Treatment of Osteoarthritis of the Knee: A Pivotal Medical Device Randomized Concurrent Controlled Study
Study identification
- NCT ID
- NCT04440189
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- GID BIO, Inc.
- Industry
- Enrollment
- 114 participants
Conditions and interventions
Conditions
Interventions
- GID SVF-2 Device System Device
Device
Eligibility (public fields only)
- Age range
- 35 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 14, 2020
- Primary completion
- Dec 29, 2024
- Completion
- Jun 29, 2025
- Last update posted
- Apr 22, 2025
2020 – 2025
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UC Davis | Sacramento | California | 95817 | — |
| Advanced Research LLC | Coral Springs | Florida | 33067 | — |
| Tulane University | New Orleans | Louisiana | 70112 | — |
| New Jersey Regenerative Institute | Cedar Knolls | New Jersey | 07927 | — |
| OrthoCarolina Research Institute | Charlotte | North Carolina | 28207 | — |
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27106 | — |
| Ohio State University Jameson Crane Sports Medicine Institute | Columbus | Ohio | 43202 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15261 | — |
| Texas Center for Cell Therapy and Research | San Antonio | Texas | 78240 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04440189, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 22, 2025 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04440189 live on ClinicalTrials.gov.